Advertisement
Australia markets open in 58 minutes
  • ALL ORDS

    7,908.10
    +8.90 (+0.11%)
     
  • AUD/USD

    0.6543
    -0.0020 (-0.30%)
     
  • ASX 200

    7,652.80
    +9.20 (+0.12%)
     
  • OIL

    77.58
    +1.09 (+1.43%)
     
  • GOLD

    2,041.00
    -8.40 (-0.41%)
     
  • Bitcoin AUD

    83,571.95
    +4,418.28 (+5.58%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

Better Growth Stock: CRISPR Therapeutics vs. Invitae

Better Growth Stock: CRISPR Therapeutics vs. Invitae

Now is a great time to load up on growth stocks because they may be among the first to benefit in the next bull market. You'll find a lot of these candidates in the area of biotech, and two possibilities that come to mind right now are gene-editing company CRISPR Therapeutics (NASDAQ: CRSP) and genetic-testing specialist Invitae (NYSE: NVTA). Which is the better growth stock to buy now?